SPECTRUM PHARMA LTD
Executive Summary
Spectrum Pharma Ltd exhibits a fragile financial position with severely diminished net assets and minimal working capital, indicating poor capability to service debt. The company’s micro-entity scale and sole director control further restrict resilience and risk mitigation. Credit facilities are not recommended at this stage without evidence of financial improvement or additional security.
View Full Analysis Report →- Legal registered address
- 8 Vernon Avenue Birmingham England B20 1DE Copied!
Latest financial results as of 12 November 2025- Current assets
- £19.05k
- Current creditors
- £18.80k
- Shareholders funds
- £251
View full financial accounts- Current assets
- £19.05k
- Current creditors
- £18.80k
- Shareholders funds
- £251
- Company number
- 13787195 Copied!
Accounts
Latest annual accounts were to 31 December 2023
Next annual accounts are due by 31 December 2025
Company financial year end is on 31 December 2025
Confirmation statement
Latest confirmation statement statement dated 6 December 2024
Next statement due by 20 December 2025
Nature of business (SIC)
86900 - Other human health activities
Latest company documents
| Date | Description |
|---|---|
| 14/02/2514 February 2025 | Confirmation statement made on 2024-12-06 with no updates |
| 06/01/256 January 2025 | Amended micro company accounts made up to 2022-12-31 |
| 31/12/2431 December 2024 | Micro company accounts made up to 2023-12-31 |
| 09/01/249 January 2024 | Confirmation statement made on 2023-12-06 with no updates |
| 31/12/2331 December 2023 | Annual accounts for year ending 31 Dec 2023 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company